CD4 and neoplasm: Compensatory immune pathways, particularly CD8+ T-cell cytotoxicity and NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC), may overcome CD4+ deficiency to contribute to tumor regression (26).